Aurobindo Pharma has received final approval from USFDA to manufacture and market Fluconazole tablets 0.25mg, 0.50mg, 1mg, 2mg, 3mg and 4mg.
Risperidone tablets is the generic version of Janssen's Risperdal tablets 0.25mg, 0.5mg, 1mg, 2mg, 3mg and 4mg and is indicated for the treatment of Schizoprenia. Risperdal tablets has sales of around US$ 1,074 million in the first half of 2008 as per the second quarterly report of Janssen Pharmaceuticals. This is Aurobindo's 81st ANDA approval from the USFDA.
The company made this announcement during the trading hours today, 13 October 2008.
No comments:
Post a Comment